Fig 1.
Development of AA during dupilumab treatment. Clinical photograph of AA after 5 weeks of treatment with dupilumab and before treatment with intralesional triamcinolone acetonide, 5 mg/mL.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.